BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

191 related articles for article (PubMed ID: 4279872)

  • 1. In vitro effects of aspirin in fibrinolysis.
    Iatridis PG; Iatridis SG; Markidou SG; Ragatz BH
    Haemostasis; 1974; 3(1):55-64. PubMed ID: 4279872
    [No Abstract]   [Full Text] [Related]  

  • 2. Effects of collagen on fibrinolysis.
    Engel AM; Alexander B
    Thromb Diath Haemorrh Suppl; 1973; 56():63-74. PubMed ID: 4376277
    [No Abstract]   [Full Text] [Related]  

  • 3. [Inhibition by ethanol and acetaldehyde the plasmin activity and plasminogen activation induced by urokinase and streptokinase].
    Roszkowska-Jakimiec W; Jurkowski J; Ostrowska H; Worowski K
    Rocz Akad Med Bialymst (1989); 1988-1989; 33-34():53-66. PubMed ID: 2979011
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Various fibrinolytic and coagulation characteristics of the blood plasma after contact with N-amyl alcohol].
    Lussa A; Tymińska-Brzósko R
    Rocz Akad Med Im Juliana Marchlewskiego Bialymst; 1979; 24():91-104. PubMed ID: 161647
    [No Abstract]   [Full Text] [Related]  

  • 5. THE ASSESSMENT OF FIBRINOLYTIC ACTIVITY IN THE BLOOD.
    FLUTE PT
    Br Med Bull; 1964 Sep; 20():195-9. PubMed ID: 14209758
    [No Abstract]   [Full Text] [Related]  

  • 6. [Molecular mechanisms of fibrinolysis and perspectives of thrombolytic therapy].
    Veremeenko KN; Kizim AI
    Vopr Med Khim; 1984; 30(5):13-22. PubMed ID: 6084892
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Substrate composition and the effect of epsilon-aminocaproic acid on tissue plasminogen activator and urokinase-induced fibrinolysis.
    Thorsen S; Astrup T
    Thromb Diath Haemorrh; 1974 Dec; 32(2-3):306-24. PubMed ID: 4281113
    [No Abstract]   [Full Text] [Related]  

  • 8. Fibrinolysis in the rat after short-term aspirin therapy.
    Housholder GT; Moorrees LL
    J Oral Surg; 1980 Jun; 38(6):412-6. PubMed ID: 6929324
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Index of fibrinolysis with new fibrin plate (author's transl)].
    Hishikawa Y; Sugie I
    Nihon Seirigaku Zasshi; 1977; 39(1):1-11. PubMed ID: 140239
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Influence of dextran sulfate and tranexamic acid on the activation of plasminogen by urokinase.
    Takada Y; Takada A
    Thromb Res; 1979; 16(5-6):865-9. PubMed ID: 160629
    [No Abstract]   [Full Text] [Related]  

  • 11. Inhibition of fibrinolytic system by liquoid (polyanetholesulfonate). A contributing factor in the liquoid-induced renal cortical necrosis.
    Gilboa N; Ryan TJ; MacColl R
    Haemostasis; 1987; 17(3):162-70. PubMed ID: 3038710
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Concepts of clot lysis.
    Francis CW; Marder VJ
    Annu Rev Med; 1986; 37():187-204. PubMed ID: 2939790
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Reaction of thrombin and proteinases of the fibrinolytic system with a mechanism-based inhibitor, 3,4-dihydro-3-benzyl-6-chloromethylcoumarin.
    Mor A; Maillard J; Favreau C; Reboud-Ravaux M
    Biochim Biophys Acta; 1990 Mar; 1038(1):119-24. PubMed ID: 2138500
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cleavage of surfactant-incorporating fibrin by different fibrinolytic agents. Kinetics of lysis and rescue of surface activity.
    Günther A; Markart P; Kalinowski M; Ruppert C; Grimminger F; Seeger W
    Am J Respir Cell Mol Biol; 1999 Dec; 21(6):738-45. PubMed ID: 10572071
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Comparative activities of amino acid and polypeptide inhibitors on natural and synthetic substrates.
    Skoza L; Tse AO; Semar M; Johnson AJ
    Ann N Y Acad Sci; 1968 Jun; 146(2):659-72. PubMed ID: 4239440
    [No Abstract]   [Full Text] [Related]  

  • 16. Inhibitors of fibrinolysis. A comparative thrombelastographic study.
    Egeblad K
    Scand J Clin Lab Invest Suppl; 1967; 98():1-69. PubMed ID: 4228724
    [No Abstract]   [Full Text] [Related]  

  • 17. Fibrinolytic agents and their effects on the haemostatic system.
    Kluft C
    Klin Wochenschr; 1988; 66 Suppl 12():50-4. PubMed ID: 2964542
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Fibrinolysis in patients with acute ischaemic heart disease. With particular reference to systemic effects of tissue-type plasminogen activator treatment on fibrinolysis, coagulation and complement pathways.
    Munkvad S
    Dan Med Bull; 1993 Sep; 40(4):383-408. PubMed ID: 8222763
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Fibrinolysis and coagulation. Effect of calcium and of coagulation on the lysis of fibrin clots.
    Helle I
    Scand J Haematol Suppl; 1968; 4():1-46. PubMed ID: 4181525
    [No Abstract]   [Full Text] [Related]  

  • 20. In vivo role of factor XII (Hageman factor) in hypercoagulability and fibrinolysis.
    Herold R; Straub PW
    J Lab Clin Med; 1972 Mar; 79(3):397-412. PubMed ID: 5061394
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 10.